- Home
- EXEL vs SKLZ Comparison
EXEL vs SKLZ Comparison
Compare EXEL & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- SKLZ
- Stock Information
- Founded
- EXEL 1994
- SKLZ 2012
- Country
- EXEL United States
- SKLZ United States
- Employees
- EXEL N/A
- SKLZ N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- SKLZ EDP Services
- Sector
- EXEL Health Care
- SKLZ Technology
- Exchange
- EXEL Nasdaq
- SKLZ Nasdaq
- Market Cap
- EXEL 11.3B
- SKLZ 106.4M
- IPO Year
- EXEL 2000
- SKLZ N/A
- Fundamental
- Price
- EXEL $44.86
- SKLZ $6.98
- Analyst Decision
- EXEL Buy
- SKLZ Buy
- Analyst Count
- EXEL 18
- SKLZ 2
- Target Price
- EXEL $43.65
- SKLZ $10.75
- AVG Volume (30 Days)
- EXEL 3.7M
- SKLZ 55.0K
- Earning Date
- EXEL 08-05-2025
- SKLZ 07-31-2025
- Dividend Yield
- EXEL N/A
- SKLZ N/A
- EPS Growth
- EXEL 237.58
- SKLZ N/A
- EPS
- EXEL 2.20
- SKLZ N/A
- Revenue
- EXEL $2,298,922,000.00
- SKLZ $92,644,000.00
- Revenue This Year
- EXEL $9.37
- SKLZ $0.20
- Revenue Next Year
- EXEL $11.05
- SKLZ $14.10
- P/E Ratio
- EXEL $20.33
- SKLZ N/A
- Revenue Growth
- EXEL 24.49
- SKLZ N/A
- 52 Week Low
- EXEL $22.13
- SKLZ $3.54
- 52 Week High
- EXEL $49.62
- SKLZ $7.50
- Technical
- Relative Strength Index (RSI)
- EXEL 56.79
- SKLZ 63.13
- Support Level
- EXEL $43.21
- SKLZ $7.15
- Resistance Level
- EXEL $48.74
- SKLZ $7.50
- Average True Range (ATR)
- EXEL 2.01
- SKLZ 0.24
- MACD
- EXEL 0.05
- SKLZ 0.02
- Stochastic Oscillator
- EXEL 31.61
- SKLZ 72.35
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.